ACO Name and Location

Cayuga Area Preferred, Inc.
101 Dates Drive
Ithaca, New York 14850


ACO Primary Contact

Primary Contact Name

Robert Lawlis

Primary Contact Phone Number

607-252-3694

Primary Contact Email Address

CAP@cayugamed.org


Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture

LUCIA JANDER MD

N

Josephine Mcallister (Dermtology Associates of Ithaca)

N

Robert Hesson

N

John Bezirganian

N

Radomir Stevanovic (Ithaca Primary Care)

N

Ann Costello

N

OB/GYN ASSOCIATES OF ITHACA, LLP

N

Surgical Associates of Ithaca, P.C.

N

Gastroenterology Associates of Ithaca PC

N

FAMILY MEDICINE ASSOCIATES OF ITHACA LLP

N

Radiology Associates of Ithaca, P.C.

N

Primary Care Internal Medicine of Ithaca, PLLC

N

Cayuga Dermatology, Pllc

N

Ann Costello

N

Robert Hesson

N

Dryden Family Medicine

N

Drs. Ferrer & Monaghan, Physicians, LLP (Drs. Ferrer and Monaghan Vein and Aesthetic Center, LLP)

N

Asthma & Allergy Associates P.C.

N

Robert J. Arleo, Md,Pc (Arleo Eye Associates)

N

David Monacelli, M.D.

N

JOHN BEZIRGANIAN

N

PATHOLOGY ASSOCIATES OF ITHACA, P.C.

N

Physiatry & Rehabilitation Medicine, PC

N

Cayuga Family Medicine Pc

N

Ithaca Urology, PLLC

N

Cayuga Anesthesia Associates, PLLC

N

Peter Schwartz, M.D., PLLC

N

CAYUGA MEDICAL ASSOCIATES, PC

N

Medical Pain Consultant, Osteopathy Of Tompkins County, P.C.

N

Cayuga Emergency Physicians, LLP

N

TRUMANSBURG MEDICINE PLLC (Trumanburg Family Health Center)

N

CAYUGA MEDICAL CENTER AT ITHACA

N

Hospicare & Palliative Care Services Of Tompkins County, Inc.

N

Jeffrey Kadlecik (Ithaca Podiatry Associates)

N

David Monacelli, M.D.

N

CARL KILGORE

N

Cayuga Ear, Nose, Throat-Head & Neck Surgery, PLLC

N

INTERNAL MEDICINE OF ITHACA, PC

N

Radomir Stevanovic (Ithaca Primary Care)

N

Josephine C. Mcallister, M.D., Llc (Dermatology Associates of Ithaca)

N

Marne Oshae Md Pllc

N

Smith Allergy And Asthma Specialists Of Cny Pc

N

KAREN LAFACE MD PLLC

N

Jose A Torrado Md Pllc (Cayuga Womens Health)

N

ADAM LAW, MD, PC (Ithaca Med)

N



ACO governing body:

Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Rudd

John

Board Chairman

1

ACO Participant

Cayuga Medical Center at Ithaca

Darlow

Lloyd

Vice Chair

1

ACO Participant

Family Medicine Associates of Ithaca, LLP

Bael

Tim

Secretary

1

ACO Participant

Cayuga Medical Center at Ithaca

Collett

John

Treasurer

1

ACO Participant

Cayuga Medical Center at Ithaca

deLima

Andreia

 

1

ACO Participant

Cayuga Medical Associates, PC

Gelber

Steve

 

1

ACO Participant

OB/GYN Associates of Ithaca, LLP

Loehr

Jamie

 

1

ACO Participant

Cayuga Family Medicine, PC

Evelyn

David

 

1

ACO Participant

Cayuga Medical Center at Ithaca

LiVigne

Thomas

 

1

Community Stakeholder, Medicare Beneficiary

 

McPheeters

Jean

 

1

Community Stakeholder, Medicare Beneficiary

 

 

 

Key ACO clinical and administrative leadership:

Robert Lawlis

ACO Executive

Martin Stallone , MD

Medical Director

Amy Carver

Compliance Officer

Martin Stallone, MD

Quality Assurance/Improvement Officer

 

 

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Clinical Integration Chairs Committee

Lloyd Darlow, MD; Chair

Contracts and Finance Committee

Elliot Rubinstein, MD; Chair

Guidelines Committee

John Costello, MD; Chair

IT Committee

John Paul Mead, MD; Chair

Performance Improvement Committee

Robert Hesson, MD; Chair

Primary Care Operations and Care Management Committee

Jamie Loehr, MD; Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Partnerships or joint venture arrangements between hospitals and ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2016, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

 

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

80.15

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

93.22

92.63

ACO-3

CAHPS: Patients' Rating of Provider

91.87

91.93

ACO-4

CAHPS: Access to Specialists

82.69

83.52

ACO-5

CAHPS: Health Promotion and Education

59.45

60

ACO-6

CAHPS: Shared Decision Making

76.9

75.28

ACO-7

CAHPS: Health Status/Functional Status

74.49

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

20.97

27.52

ACO-8

Risk-Standardized, All Condition Readmission

15.23

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

19.66

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

48.45

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

61.51

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

51.54

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

8.33

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

14.78

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

63.64

82.72

ACO-39

Documentation of Current Medications in the Medical Record

95.77

87.54

ACO-13

Falls: Screening for Future Fall Risk

64.51

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

70.03

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

84.85

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

70.95

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

92.23

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

19.35

53.63

ACO-19

Colorectal Cancer Screening

78.45

61.52

ACO-20

Breast Cancer Screening

80.08

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

85.6

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

74.83

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

14.23

18.24

ACO-41

Diabetes: Eye Exam

62.85

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

61.36

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

91.32

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

84.38

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF <40%)

73.22

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.    

 

Note: In the Quality Performance Results file(s) above, search for “Cayuga Area Preferred, Inc.” to view the quality performance results. This ACO can also be found by using the ACO ID A3195 in the public use files on data.cms.gov.

Payment Rule Waivers

·        No, our ACO does not use the SNF 3-Day Rule Waiver.